TORONTO, April 13 /PRNewswire/ - Katz Group Canada Ltd., Canada's largest integrated pharmacy network, today announced the appointment of Frank Scorpiniti as Chief Operating Officer.

With more than 20 years of retail pharmacy experience, Mr. Scorpiniti was previously Senior Vice President, Pharmacy Operations at Duane Reade, a New York-based chain recognized as one of North America's most innovative retail pharmacy chains. Prior to Duane Reade, Mr. Scorpiniti held positions of increasing responsibility at Longs Drug Stores, a west coast regional pharmacy chain. He began his career as a pharmacist and is a graduate of the University of the Pacific, School of Pharmacy in Stockton, California.

"Frank is a strategic thinker who has a passion for the retail pharmacy industry and a proven ability to drive growth and performance within an organization," said Andy Giancamilli, Chief Executive Officer, Katz Group Canada Ltd. "We are confident that Frank's leadership and experience will help enhance the customer experience across our network of corporate, franchise and banner pharmacies." Mr. Scorpiniti will be responsible for Rexall retail operations, Drug Trading Company Limited and Medicine Shoppe Canada Inc.

The company is also pleased to announce the appointment of Warren Jeffery to the role of Chief Development Officer which he'll assume in addition to his current role as Interim Chief Merchandising Officer. Reporting directly to Mr. Giancamilli, Mr. Jeffery will lead the company's productivity and growth initiatives.

About Katz Group Canada Ltd./Rexall
Katz Group Canada Ltd. is Canada's leading integrated retail pharmacy network encompassing more than 1,800 chain, franchise and independent pharmacies across the country.  Pharmacy banners include Rexall, Rexall Pharma Plus, The Medicine Shoppe, Guardian, I.D.A.  Katz Group's holdings also include Rexall Specialty Pharmacy, Rexall Direct, Rexall Health Services and ProPharm Limited. For more information visit, www.rexall.ca.

SOURCE Katz Group Canada Ltd.